The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 05, 2023
Filed:
Nov. 17, 2016
Applicant:
Calgent Biotechnology Co., Ltd., Taipei, TW;
Inventors:
Assignee:
Calgent Biotechnology Co., Ltd., Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 1/16 (2006.01); A61K 31/4706 (2006.01); A61K 31/166 (2006.01); A61K 45/06 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/426 (2006.01); A61K 31/4409 (2006.01); C07C 15/00 (2006.01); A61P 11/00 (2006.01); A61K 31/40 (2006.01); A61K 31/404 (2006.01); A61K 31/415 (2006.01); A61K 31/416 (2006.01); A61K 31/4184 (2006.01); A61K 31/437 (2006.01); A61K 31/44 (2006.01); A61K 31/4402 (2006.01); A61K 31/4406 (2006.01); A61K 31/4453 (2006.01); A61K 31/47 (2006.01); A61K 31/495 (2006.01); A61K 31/4965 (2006.01); A61K 31/505 (2006.01); A61K 31/519 (2006.01); A61K 31/5375 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/166 (2013.01); A61K 9/20 (2013.01); A61K 9/48 (2013.01); A61K 31/40 (2013.01); A61K 31/404 (2013.01); A61K 31/415 (2013.01); A61K 31/416 (2013.01); A61K 31/4184 (2013.01); A61K 31/426 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/4402 (2013.01); A61K 31/4406 (2013.01); A61K 31/4409 (2013.01); A61K 31/4453 (2013.01); A61K 31/47 (2013.01); A61K 31/4706 (2013.01); A61K 31/495 (2013.01); A61K 31/4965 (2013.01); A61K 31/505 (2013.01); A61K 31/519 (2013.01); A61K 31/5375 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2018.01); C07C 15/00 (2013.01); A61K 9/0019 (2013.01);
Abstract
The invention relates to the use of a compound of Formula (I) as described herein and its effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.